Sign in
Active, not recruitingNo phase

Shoulder RFA Pilot Study

Key facts

Who runs it
University of Utah
Where
Farmington, Salt Lake City, and South Jordan, United StatesSee the 3 sites
Trial code
Status
Active, not recruiting
People taking part
10 people, planned
Started
7 Feb 2024
Expected to end
Dec 2026
Type of study
Observational
Record updated
13 April 2026

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (19)Hide the full registry criteria

Who can take part

  • ≥50 years old capable of understanding and providing consent in English, and capable of complying with the outcome instruments used
  • ≥3 months of shoulder pain refractory to conventional treatment (i.e., physiotherapy, medication, steroid injections)
  • Persistent shoulder pain ≥ 4/10 in intensity on a 7-day average
  • Shoulder pain refractory to conventional treatment (i.e., physical therapy, oral analgesics, steroid injection)
  • Prior consultation with a board-certified orthopedic shoulder surgeon, deemed a non-surgical candidate for the primary diagnosis of glenohumeral joint pain +/- rotator cuff pain
  • ≥80% pain relief for at least 30 minutes after a single fluoroscopically-guided block of the sensory branches of the SN, AN, and LPN with 0.5 mL of lidocaine at each nerve
  • Scheduled for procedure of interest

Who cannot take part

  • Previous partial/total/reverse shoulder arthroplasty. Participants with a history of RTC repair will not be excluded
  • Intraarticular or subacromial injection to the study shoulder within 3 months before C-SRFA
  • Prior shoulder radiofrequency ablation
  • Infection
  • Allergy to any medication needed to participate in this study
  • Neurologic disorders including radiculopathy, connective tissue/inflammatory joint disease/widespread soft tissue pain disorder
  • Severe, uncontrolled psychiatric disorder requiring hospitalization within 6 months
  • Uncontrolled bleeding diathesis
  • Pregnancy
  • Pacemaker, neurostimulator, or other implanted device potentially sensitive to RF energy
  • Active Worker's compensation claim, litigation, or other possible reason for secondary gain
  • Daily opioid use

Where in United States

  • University of Utah, Farmington Health CenterFarmington, United States
  • University of Utah Orthopaedic CenterSalt Lake City, United States
  • University of Utah South Jordan Health CenterSouth Jordan, United States

About the trial

What the trial wants to find out

Through this prospective, single-arm cohort pilot study, we plan to explore the safety and effectiveness of Shoulder Radiofrequency Ablation (SRFA) in patients with non-operative chronic shoulder pain due to shoulder osteoarthritis with or without rotator cuff tears.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effectiveness of Shoulder Terminal Sensory Articular Nerve Radiofrequency Ablation for Non-surgical Refractory Shoulder Pain Due to Rotator Cuff Pathology and Osteoarthritis; A Prospective Pilot Study
Record updated
13 April 2026